SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. It focuses on the research and development for medicinal cannabis pharmaceutical products and psychedelic medicine therapies for treatment of a range of indications. The company was founded on April 27, 2001 and is headquartered in Norwest, Australia.

Incannex Healthcare Inc

Incannex Healthcare Limited - ADR

Incannex Healthcare (IXHL) is experiencing a surge in momentum, largely driven by its imminent NASDAQ compliance and intense speculation surrounding potential positive End-of-Phase 2 results for its Fast Track-designated sleep apnea drug. The community is actively discussing the stock's severely undervalued market cap relative to its cash and pipeline, anticipating a significant re-rating and potential short squeeze from the newly tightened float.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is trending after reporting robust quarterly earnings, including beats on revenue and EPS, achieving full-year GAAP profitability, and announcing a significant new share buyback, which sparked a perplexing after-hours dip. The community is actively debating whether this decline is market manipulation or an exceptional buying opportunity, particularly given the company's strategic pivot into Agentic AI and discussions around potential government contracts.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. It offers Alpha, Beta, Gamma, and orbital transfer vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 27, 2017 and is headquartered in Cedar Park, TX.

Firefly Aerospace Inc.

Firefly Aerospace is trending following the successful Alpha Flight 7 mission, generating significant community excitement and bullish sentiment. This launch success, combined with its inclusion in the lucrative "Golden Dome" defense initiative and broader sector enthusiasm, is fueling discussions about the company's growth trajectory.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital (NUAI) is trending on strong anticipation of a major hyperscaler tenant announcement for its expanding AI data center campus, amplified by recent strategic land acquisitions for significant power generation capacity. The community is buzzing about its potential in the critical energy-digital infrastructure sector, despite some impatience surrounding the timing of the official news.

Lightwave Logic, Inc. is a development stage company which engages in the commercialization of electro-optic photonic devices. The firm offers the P2ICTM technology platform which uses in-house proprietary organic polymers. Its products include electro-optical modulation devices and proprietary polymer photonic integrated circuits. The company was founded on June 24, 1997 and is headquartered in Englewood, CO.

Lightwave Logic Inc

Lightwave Logic is surging after announcing a development agreement with Tower Semiconductor to integrate its electro-optic polymer modulators into Tower's silicon photonics platform, with the community actively discussing the potential Nvidia connection and its implications for next-generation AI and data center optical interconnects.

Icahn Enterprises LP is a holding company. It operates through the following segments: Investment, Automotive, Energy, Food Packaging, Real Estate, Home Fashion, Pharma, and Holding Company. The Investment segment consists of various private investment funds. The Automotive segment holds ownership in Icahn Automotive Group, LLC. The Energy segment refers to petroleum refining and marketing businesses. The Food Packaging segment involves the production and sale of cellulosic, fibrous, and plastic casings for the processed meat and poultry industry. The Real Estate segment offers rental real estate, property development, and resort activities. The Home Fashion segment deals with manufacturing, sourcing, marketing, distributing, and selling home fashion consumer products. The Pharma segments operate through Vivus, Inc., a specialized pharmaceutical company. The Holding Company segment manages acquisition and investment in operating businesses. The company was founded on February 17, 1987 and is headquartered in Sunny Isles Beach, FL.

Icahn Enterprises L P - Unit

Icahn Enterprises, L.P.

Investors are actively debating the high distribution yield of Icahn Enterprises and potential for a short squeeze, fueled by optimism surrounding its CVI Energy holdings benefiting from current energy market dynamics and its indirect exposure to a possible SpaceX IPO. This comes as the company continues strategic asset realignments and Carl Icahn makes new investments, keeping the community focused on dividend sustainability and future growth.

iShares Trust - iShares Russell 2000 ETF

iShares Russell 2000 ETF

The iShares Russell 2000 ETF (IWM) is a central topic of discussion as small-cap stocks face heightened pressure from escalating geopolitical tensions and rising oil prices. The community is actively debating its notable underperformance and greater sensitivity compared to broader market indices during this period of uncertainty.

Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.

Regeneron Pharmaceuticals, Inc.

Regeneron is actively discussed due to recent label expansions for its oncology drug Libtayo and promising gene therapy data for hearing loss, bolstering its diverse pipeline, even as persistent manufacturing issues delay a key Eylea HD pre-filled syringe and intensify market competition in ophthalmology.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is trending as escalating attacks disrupt shipping in the Strait of Hormuz, driving crude oil prices higher despite a historic 400 million barrel global reserve release, fueling a sharp debate among investors on whether prices will continue to surge or eventually crash.

Syndax Pharmaceuticals, Inc. engages in the development of cancer therapies. Its products include SyndAccess, Revuforj, Niktimvo, and IncyteCARES. The company was founded by Richard A. Heyman, Eckard Weber, Peter Ordentlich, Ronald M. Evans and Michael Downes on October 11, 2005 and is headquartered in New York, NY.

Syndax Pharmaceuticals Inc

Syndax Pharmaceuticals is trending as analysts, including JPMorgan and Citigroup, raise price targets to $45 and $57 respectively, while investors eagerly anticipate upcoming data presentations at the ASH conference. The community is actively debating the company's significant undervaluation, strong commercial traction of its oncology drugs Revuforj and Niktimvo, and escalating buyout speculation, particularly with partner Incyte.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Hotel101 Global Holdings Corp. (NASDAQ:HBNB) Short Interest Up 169.2% in February

Hotel101 Global Holdings Corp. (NASDAQ:HBNB - Get Free Report) was the target of a large increase in short interest during the month of February. As of February 27th, there was short interest...

Hotel101 Global (NASDAQ:HBNB) Shares Gap Down - Time to Sell?

Hotel101 Global (NASDAQ:HBNB) Shares Gap Down - Time to Sell...

Hotel101 Global (NASDAQ:HBNB) Trading 7% Higher - Should You Buy?

Hotel101 Global (NASDAQ:HBNB) Stock Price Up 7% - What's Next...

Hotel101 Global Holdings Corp. (NASDAQ:HBNB) Short Interest Down 41.8% in January

Hotel101 Global Holdings Corp. (NASDAQ:HBNB - Get Free Report) was the target of a significant decline in short interest in the month of January. As of January 30th, there was short interest totaling...

Hotel101 Global Holdings Corp. (NASDAQ:HBNB) Short Interest Down 33.3% in January

Hotel101 Global Holdings Corp. (NASDAQ:HBNB - Get Free Report) was the target of a significant drop in short interest in January. As of January 15th, there was short interest totaling 16,084 shares...

Hotel101 Global (NASDAQ:HBNB) Stock Price Down 7.2% - Here's What Happened

Hotel101 Global (NASDAQ:HBNB) Shares Down 7.2% - Should You Sell...

Hotel101 Global (NASDAQ:HBNB) Shares Gap Down - Here's What Happened

Hotel101 Global (NASDAQ:HBNB) Shares Gap Down - Should You Sell...

Hotel101 Global Holdings Corp. (NASDAQ:HBNB) Short Interest Update

Hotel101 Global Holdings Corp. (NASDAQ:HBNB - Get Free Report) saw a large growth in short interest during the month of December. As of December 31st, there was short interest totaling 24,130 shares...

Hotel101 Global (NASDAQ:HBNB) Hits New 12-Month High - Should You Buy?

Hotel101 Global (NASDAQ:HBNB) Reaches New 12-Month High - Here's What Happened...

Hotel101 Global (NASDAQ:HBNB) Reaches New 12-Month High - Still a Buy?

Hotel101 Global (NASDAQ:HBNB) Sets New 52-Week High - Still a Buy...

Hotel101 Global Holdings Corp. engages in the development and sale of real estate and hotel units. The company was founded by Edgar J. Sia II and Tony Tan Caktiong on March 13, 2024 and is headquartered in Singapore.

HBNB
JVSPAC Acquisition Corp.

Feed

News

Sentiment

Fundamentals

Info

Latest HBNB News

HBNBJVSPAC Acquisition Corp.